-
Training in emerging advances in chronic hepatitis C infection in Pakistan: the Teach - Pak project
Authors: Faisal W Ismail, Shahab Abid, Minaz Mawani, Wasim Jafri, Saeed S Hamid
Highlights from the 2017 Egyptian International Hepatology Preceptorship Program
Professor Ashraf Omar
Watch07:31 min
-
-
-
-
-
-
-
E. Estrabaud and P. Marcellin
Supported by: AbbVie, Bristol-Myers Squibb, and Gilead Sciences
Watch17:22 min
-
Adrian Di Bisceglie, MD
Supported by: AbbVie, Bristol-Myers Squibb, and Gilead Sciences
Watch17:26 min
Geoffrey McCaughan, MD
Supported by: AbbVie, Bristol-Myers Squibb, and Gilead Sciences
Watch17:38 min
-
-
-
-
-
-
-
-
-
-
Seng Gee Lim, Singapore
Supported by: AbbVie, Bristol-Myers Squibb and Gilead Sciences
Watch10:16 min
-
Teerha Piratvisuth, Thailand
Supported by: AbbVie, Bristol-Myers Squibb and Gilead Sciences
Watch15:47 min
-
Stefan Zeuzem, Germany
Supported by: AbbVie, Bristol-Myers Squibb and Gilead Sciences
Watch18:17 min
-
R. Gish & M. Schiffman, USA
Supported by: AbbVie, Bristol-Myers Squibb and Gilead Sciences
Watch37:01 min
Stefan Zeuzem, Germany
Supported by: AbbVie, Bristol-Myers Squibb and Gilead Sciences
Watch16:38 min
Mitchell Shiffman, USA
Supported by: AbbVie, Bristol-Myers Squibb and Gilead Sciences
Watch21:55 min
-
Jai Horng Kao, Taiwan
Supported by: AbbVie, Bristol-Myers Squibb and Gilead Sciences
Watch20:33 min
Dan Yock Young, Singapore
Supported by: AbbVie, Bristol-Myers Squibb and Gilead Sciences
Watch17:04 min
-
Dan Yock Young, Singapore
Supported by: AbbVie, Bristol-Myers Squibb and Gilead Sciences
Watch16:37 min
Seng Gee Lim, Singapore
Supported by: AbbVie, Bristol-Myers Squibb and Gilead Sciences
Watch11:04 min
-
Hugo Cheinquer, MD PhD
Supported by: AbbVie, Bristol-Myers Squibb and Gilead Sciences
Watch20:32 min
-
J. Francisco Sánchez-Avila, MD
Supported by: AbbVie, Bristol-Myers Squibb and Gilead Sciences
Watch21:17 min
E. Ridruejo and M. Guimarães
Supported by: AbbVie, Bristol-Myers Squibb and Gilead Sciences
Watch55:53 min
-
Tarik Asselah, MD, PhD
Supported by: AbbVie, Bristol-Myers Squibb and Gilead Sciences
Watch8:03 min